Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Concerns About Conclusions of Self-monitoring of Blood Glucose

Concerns About Conclusions of Self-monitoring of Blood Glucose Letters tinuous rather than distinctive entities or the cost-benefit ra- We agree with Dr Yang and colleagues that when modify- tio reaches an unfordable level. Answers to these questions de- ing a disease definition, it is essential to consider whether the pend greatly on the values of the population concerned and additional patients classified with the expanded definition war- 2-4 resources available. rant clinical intervention, as well as whether this net benefit Our recent study showed that the changes in the cutoffs should be paid for. Such decisions should include consider- for diagnosing hypertension, hypercholesterolemia, and dia- ation of the regional variations in the values of the popula- betes mellitus around the year 2000 resulted in doubling the tion concerned and their available resources. In our check- prevalence of all the 3 conditions in China. If the new patients list, we recommended that the definition should reflect the were all treated with drugs, the annual drug costs alone would values and preferences of patients and the wider community consume 56% of the government’s total health expenditure in and include the impact on resource usage. 2010. Regardless of the benefit of treating these conditions, Dr Yang and colleagues have highlighted http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Concerns About Conclusions of Self-monitoring of Blood Glucose

Loading next page...
 
/lp/american-medical-association/concerns-about-conclusions-of-self-monitoring-of-blood-glucose-lUifLvmbh4
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2017.6142
Publisher site
See Article on Publisher Site

Abstract

Letters tinuous rather than distinctive entities or the cost-benefit ra- We agree with Dr Yang and colleagues that when modify- tio reaches an unfordable level. Answers to these questions de- ing a disease definition, it is essential to consider whether the pend greatly on the values of the population concerned and additional patients classified with the expanded definition war- 2-4 resources available. rant clinical intervention, as well as whether this net benefit Our recent study showed that the changes in the cutoffs should be paid for. Such decisions should include consider- for diagnosing hypertension, hypercholesterolemia, and dia- ation of the regional variations in the values of the popula- betes mellitus around the year 2000 resulted in doubling the tion concerned and their available resources. In our check- prevalence of all the 3 conditions in China. If the new patients list, we recommended that the definition should reflect the were all treated with drugs, the annual drug costs alone would values and preferences of patients and the wider community consume 56% of the government’s total health expenditure in and include the impact on resource usage. 2010. Regardless of the benefit of treating these conditions, Dr Yang and colleagues have highlighted

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Dec 1, 2017

References